Islet failure in type 2 diabetes (T2DM) is characterised by loss of glucose-stimulated insulin secretion (GSIS) attributed in part to β-cell dedifferentiation (e.g., mis-expression of alpha cell-specific genes). Recent single cell transcriptomics studies identified SLC4A4 (a gene encoding an electrogenic Na+-nHCO3- cotransporter, NBCe1) as one of the mis-expressed genes in β-cells of patients with T2DM. Thus, we set out to test the hypothesis that mis-expression of SLC4A4 in β-cells contributes to loss of GSIS and impaired glucose homeostasis in T2DM. To address this hypothesis, we first confirmed induction of robust SLC4A4 protein expression in β-cells of patients with T2DM utilizing immunofluorescence staining of autopsy-derived human pancreas specimens. We next generated β-cell-specific slc4a4 knockout (β-slc4a4-/-) and corresponding control (β-slc4a4+/+) mice through crossing of slc4a4 loxP/loxP and Ins2-Cre mouse models. Adult (3 month old) β-slc4a4-/- mice displayed normal body weight, glycaemia, glucose tolerance and insulin sensitivity under standard chow fed conditions (p>0.vs. β-slc4a4+/+). In contrast, β-slc4a4-/- mice exhibited enhanced glucose tolerance and in vivo glucose-stimulated insulin response under conditions of metabolic stress induced by ad libitum intake of 60% high fat diet (HFD) for 8 weeks (p<0.vs. β-slc4a4+/+ HFD). Interestingly, improved glucose tolerance in β-slc4a4-/-mice was also associated with a tendency for expansion of β-cellsmass (82%, p=0.09 vs. β-slc4a4+/+ HFD) and increased β-cellsproliferation (26%, p=0.11 vs. β-slc4a4+/+ HFD). These results suggest that β-cell mis-expression of the Na+-nHCO3- cotransporter encoded by SLC4A4 contributes to induction of β-cell failure under conditions of metabolic stress and T2DM.

Disclosure

M. Brown: None. H.L. Holmes: None. K. Rakshit: None. M.F. Romero: None. A. Matveyenko: None.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.